https://scholars.lib.ntu.edu.tw/handle/123456789/628258
標題: | Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Asian Multiregional, Randomized Study | 作者: | YEONG-SHIAU PU Ahn, Hanjong Han, Weiqing Huang, Shu-Pin Wu, Hsi-Chin Ma, Lulin Yamada, Shunsuke Suga, Kazutaka Xie, Li-Ping |
關鍵字: | Asia; Castration-resistant prostate cancer; Enzalutamide; Metastasis; Treatment efficacy | 公開日期: | 六月-2022 | 出版社: | SPRINGER | 卷: | 39 | 期: | 6 | 起(迄)頁: | 2641 | 來源出版物: | Advances in therapy | 摘要: | Enzalutamide significantly improved clinical outcomes compared with placebo in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) with disease progression despite androgen deprivation therapy (ADT) in the PREVAIL study. However, few patients from Asia were enrolled. Our study (NCT02294461) aimed to evaluate the safety and efficacy of enzalutamide in this disease setting in patients in mainland China, Korea, Taiwan, and Hong Kong. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/628258 | ISSN: | 0741-238X 1865-8652 |
DOI: | 10.1007/s12325-022-02140-2 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。